State-of-the-Art Clinical Symposium


Apr 29 - 30, 2017


Chicago, IL

Program Information

This clinical symposium will expose you to a range of content delivered by key opinion leaders in areas such as therapeutic developments, recent research findings and scientific advances, all delivered in an environment conducive to dialogue and networking.

Program Schedule

Coming soon

Registration & Fees

Coming soon


Coming soon


Airline Reservations
To make your airline or car rental reservations, contact ACR's travel agency. Be sure to book early to obtain the best travel options. 

Association Travel Concepts:
Phone: 800-755-3899 or 858-362-2719

Airport Options
O'Hare International Airport - 18 miles to hotel
Midway Airport - 10 miles to hotel

Ground Transportation Options
Go Airport Express Shuttle:
Phone: 888-284-3826

For additional travel information, visit or contact the hotel concierge. Hotel parking: Valet nightly parking is $51 with in-out privileges; self-parking is $39 per 24 hour period.


2016 Syllabi
To access the 2016 syllabus, login to your ACR Learning Center account. Note: this is a separate login form your login. If you have any questions or login challenges, contact

2015 Syllabi
To ensure you have the most updated copy of each speaker's presentation, program syllabi will be available online during and after the symposium for up to one year (registered attendees only). Login to locate the program syllabi >

CME and MOC Information

Accreditation Statement
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The ACR designates this live activity for a maximum of 17.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants can claim up to 1.0 AMA PRA Category 1 Credit™ for completing the pre-and post-assessments, and up to 12.0 AMA PRA Category 1 Credits™ for attending the State-of-the-Art Clinical Symposium. Attendees of the FIT at SOTA pre-conference can claim up to an additional 4 hours (for a maximum of 17). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The State-of-the-Art Clinical Symposium does not offer ABIM MOC points.

Learning Objectives
Upon completion of this program, you should be able to:

  • Discuss the most up-to-date evidence-based treatment approaches in the management of patients with rheumatic diseases
  • Identify and describe recent scientific and clinical advances regarding pathogenesis of rheumatic diseases

Target Audience
This program is designed for rheumatologists, physicians and other healthcare providers who care for patients with rheumatic diseases and those interested or engaged in research in the field of rheumatology.

Corporate Support

Educational grant support for this activity has been provided by:
Lilly USA, LLC
Sanofi US and Regeneron Pharmaceuticals
Celgene Corporation

Pre-Symposium Activities

Coming soon

Press Registration & Policies

The American College of Rheumatology welcomes members of the press to write about research presented at our professional meetings, such as the State-of-the-Art Clinical Symposium (SOTA), throughout the year. Complimentary registration is provided to approved members of the press to allow them to attend sessions on-site. All members of the press interested in attending SOTA must register by (date to be announced). On-site registration will NOT be available.  Registration details are coming soon. Please note: meals are not included as part of the complimentary registration. A $100 fee is required to access meals during the State-of-the-Art Clinical Symposium.


Coming soon

Registration Info

Key Dates

  • TBD - Early Bird Registration Deadline
  • TBD - Housing Deadline 
  • TBD - Advance Registration Deadline 

Contact Info / Inquiries

Registration Support Center
800-636-4766 (US & Canada)
415-979-2265 (International)

404-633-3777, ext. 381